Clifton Mining Company Inc. (OTC : CFTN)
ALPINE, UT, Aug. 4 /CNW/ - American Biotech Labs, LLC (ABL) is a private
Company that produces products using SilverSol Technology(TM) that is both
benign and a broad-spectrum anti-pathogenic. Clifton Mining Company (Clifton)
is the largest shareholder of ABL, owning approximately 21% of the shares.
For the first six months of 2008 ABL reports that its sales increased by
50% over the corresponding period of 2007. This increase does not include any
sales from new contracts in South and East Asia and the Middle East. The
company believes these will be important markets in the future.
Extraordinary expenses including legal and patent costs associated with
procuring patents in these new countries, reduced profitability. Yet even with
these expenses, ABL declared an interim profit distribution to shareholders,
which yielded $77,000 to Clifton.
While there can be no assurances of these, IF sales increase at this rate
for the next couple of years and IF extraordinary expenses do not increase,
then distributions from ABL should be sufficient to cover Clifton's general
We look forward to seeing all those shareholders who can attend the
annual shareholder meeting scheduled for the 29th of August, 2008 at 12 pm.
Alpine Arts Center 450 Alpine Hwy, Alpine, UT 84004, (801) 763-7173.
Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward
looking are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Editors and investors are cautioned
that forward looking statements invoke risk and uncertainties that may affect
the company's business prospects and performance.
For further information:
For further information: Dr. Ken Friedman, President at (303) 642-0659,
or Keith Moeller, Vice President at (801) 756-1414 or see the websites at
www.cliftonmining.com and see information on ABL at